More about

Oregon Health And Science University

News
September 29, 2022
2 min read
Save

Upadacitinib significantly improves non-radiographic axial SpA signs, symptoms vs placebo

Upadacitinib significantly improves non-radiographic axial SpA signs, symptoms vs placebo

Upadacitinib demonstrated significant improvements in patients with non-radiographic axial spondyloarthritis when compared with a placebo at 14 weeks, according to data published in The Lancet.

News
September 15, 2022
2 min read
Save

Osilodrostat normalizes urinary free cortisol in Cushing’s disease for most at 72 weeks

Osilodrostat normalizes urinary free cortisol in Cushing’s disease for most at 72 weeks

More than 80% of adults with Cushing’s disease receiving osilodrostat had normalized mean urinary free cortisol levels at 72 weeks of treatment, according to findings from the LINC 3 study extension.

News
August 17, 2022
1 min read
Save

Invasive mechanical ventilation improves survival among patients hospitalized with dementia, pneumonia

Invasive mechanical ventilation improves survival among patients hospitalized with dementia, pneumonia

Invasive mechanical ventilation improved 30-day survival in patients with advanced dementia hospitalized with pneumonia compared with noninvasive ventilation, despite lack of 1-year survival benefit and higher health care costs.

News
July 14, 2022
3 min read
Save

AHA: More mental health support needed in pediatric, adult congenital heart disease

AHA: More mental health support needed in pediatric, adult congenital heart disease

The psychological needs of people with congenital heart disease remain largely unmet despite research suggesting mental health support is critical for quality of life, according to an American Heart Association scientific statement.

News
June 20, 2022
2 min read
Save

Oral octreotide efficacy maintained in more than 90% of adults with acromegaly at 3 years

Oral octreotide efficacy maintained in more than 90% of adults with acromegaly at 3 years

ATLANTA — More than 90% of adults with acromegaly remained responders to oral octreotide 3 years after initiating treatment, according to findings from the MPOWERED open-label extension study presented at ENDO 2022.

News
June 14, 2022
2 min read
Save

Pathogenic germline variants identified in adults with acute myeloid leukemia

Pathogenic germline variants identified in adults with acute myeloid leukemia

Approximately 14% of adults with acute myeloid leukemia harbored germline pathogenic or likely pathogenic variants in a hematologic malignancy predisposition gene, according to study results published in Blood.

News
June 12, 2022
4 min watch
Save

VIDEO: New Cushing’s, acromegaly drug data prominent at ENDO annual meeting

VIDEO: New Cushing’s, acromegaly drug data prominent at ENDO annual meeting

ATLANTA — In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary research presented at the annual meeting of the Endocrine Society in Atlanta.

News
April 28, 2022
2 min read
Save

Interventions reduce opioid prescribing after neck dissection for thyroid cancer

Interventions reduce opioid prescribing after neck dissection for thyroid cancer

DALLAS — Preoperative counseling and perioperative pain management strategies significantly reduced opioid prescriptions at discharge for patients who underwent lateral neck dissection for thyroid cancer, according to study results.

News
April 05, 2022
2 min read
Save

Racial, ethnic disparities persist in pediatric acute care use for asthma

Racial, ethnic disparities persist in pediatric acute care use for asthma

A new study highlights different patterns of clinic and ED acute care use for asthma among non-Hispanic Black and bilingual Latino children compared with non-Hispanic white children.

News
April 01, 2022
3 min read
Save

Adults with acromegaly have more comorbidities, prescribed more concomitant medications

Adults with acromegaly have more comorbidities, prescribed more concomitant medications

Adults with acromegaly have more comorbidities and are prescribed more concomitant medications than those without acromegaly, according to study findings published in Pituitary.

View more